AIDA
Modify Date: 2024-01-08 00:02:35
AIDA structure
|
Common Name | AIDA | ||
|---|---|---|---|---|
| CAS Number | 168560-79-0 | Molecular Weight | 221.20900 | |
| Density | 1.481 g/cm3 | Boiling Point | 470.4ºC at 760 mmHg | |
| Molecular Formula | C11H11NO4 | Melting Point | N/A | |
| MSDS | USA | Flash Point | 238.3ºC | |
Use of AIDAUPF-523 (AIDA), a rigid (carboxyphenyl) glycine derivative, is a relatively potent and selective antagonist of group I metabotropic glutamate receptors (mGlu1a) with an IC50 of 214 μM. But UPF-523 has no effect on group II (mGlu2), group III (mGlu4) receptors or ionotropic glutamate receptors. UPF-523 has the potential for the research of the acute arthritis[1][2]. |
| Name | (RS)-1-Aminoindan-1,5-dicarboxylicacid |
|---|---|
| Synonym | More Synonyms |
| Description | UPF-523 (AIDA), a rigid (carboxyphenyl) glycine derivative, is a relatively potent and selective antagonist of group I metabotropic glutamate receptors (mGlu1a) with an IC50 of 214 μM. But UPF-523 has no effect on group II (mGlu2), group III (mGlu4) receptors or ionotropic glutamate receptors. UPF-523 has the potential for the research of the acute arthritis[1][2]. |
|---|---|
| Related Catalog | |
| Target |
mGluR1a:214 μM (IC50) |
| In Vivo | UPF-523 (0.18 mg/kg; i.p.; 0.5 ml per 100 g) results in a final concentration of 100–150 mM which is below an IC50 of 214 mM[1]. Animal Model: Naive male hooded Lister rats (320–350 g)[1] Dosage: 0.18 mg/kg Administration: I.p.; 0.5 ml per 100 g Result: Showed no gross motor abnormalities and normal righting reflexes. |
| References |
| Density | 1.481 g/cm3 |
|---|---|
| Boiling Point | 470.4ºC at 760 mmHg |
| Molecular Formula | C11H11NO4 |
| Molecular Weight | 221.20900 |
| Flash Point | 238.3ºC |
| Exact Mass | 221.06900 |
| PSA | 100.62000 |
| LogP | 1.26990 |
| Vapour Pressure | 1.19E-09mmHg at 25°C |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S37/39 |
| RIDADR | NONH for all modes of transport |
| HS Code | 2922499990 |
| HS Code | 2922499990 |
|---|---|
| Summary | HS:2922499990 other amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0% |
|
Bordetella pertussis Adenylate Cyclase Toxin Blocks Induction of Bactericidal Nitric Oxide in Macrophages through cAMP-Dependent Activation of the SHP-1 Phosphatase.
J. Immunol. 194 , 4901-13, (2015) The adenylate cyclase toxin-hemolysin (CyaA) plays a key role in the virulence of Bordetella pertussis. CyaA penetrates complement receptor 3-expressing phagocytes and catalyzes uncontrolled conversio... |
|
|
Cross talk between ABC transporter mRNAs via a target mRNA-derived sponge of the GcvB small RNA.
EMBO J. 34 , 1478-92, (2015) There is an expanding list of examples by which one mRNA can posttranscriptionally influence the expression of others. This can involve RNA sponges that sequester regulatory RNAs of mRNAs in the same ... |
|
|
In vivo evaluation of porous silicon and porous silicon solid lipid nanocomposites for passive targeting and imaging.
Mol. Pharm. 11(8) , 2876-86, (2014) The use of nanoparticle carriers for the sustained release of cytotoxic drugs in cancer therapy can result in fewer adverse effects and can thus be of great benefit for the patient. Recently, a novel ... |
| 1-AMINOINDAN-1,5-DICARBOXYLIC ACID,UPF 5 23 |
| MFCD00672638 |
| (R,S)-1-Aminoindane-1,5 |
| Valerenic acid |
| 1-Amino-2,3-dihydro-1H-indene-1,5-dicarboxylic acid,1-Aminoindan-1,5-dicarboxylic acid |